Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Androgens and abdominal obesity.

P Mårin1, S Arver

  • 1Department of Heart and Lung Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden.

Bailliere'S Clinical Endocrinology and Metabolism
|May 20, 1999
PubMed
Summary

Visceral obesity is linked to metabolic syndrome and cardiovascular risks. Correcting low testosterone in men with metabolic syndrome can reduce abdominal fat and improve glucose and lipid levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Origin of the high coercivity in FeNi inspired magnets.

Scientific reports·2026
Same author

Pharmacokinetics of tildipirosin in estuarine (Crocodylus porosus) and freshwater (Crocodylus siamensis) crocodiles.

Veterinary journal (London, England : 1997)·2024
Same author

Adipokine secretion and lipolysis following gender-affirming treatment in transgender individuals.

Journal of endocrinological investigation·2024
Same author

Self-assembly of iron oxide precursor micelles driven by magnetic stirring time in sol-gel coatings.

RSC advances·2022
Same author

Effect of preoperative radiotherapy for rectal cancer on spermatogenesis.

The British journal of surgery·2021
Same author

Detection of Approximal Caries Lesions in Adults: A Cross-sectional Study.

Operative dentistry·2019

Area of Science:

  • Endocrinology
  • Metabolic Syndrome Research
  • Cardiovascular Disease Etiology

Background:

  • Central or visceral obesity is a significant risk factor for cardiovascular disease and type 2 diabetes mellitus.
  • Metabolic syndrome, characterized by visceral obesity, dyslipidemia, hypertension, and impaired glucose tolerance, is a major contributor to cardiovascular morbidity and mortality.
  • While certain endocrine disorders like hypercortisolism cause obesity with abdominal fat accumulation, subtle, borderline endocrinopathies are increasingly recognized in metabolic syndrome.

Purpose of the Study:

  • To investigate the role of subtle endocrinopathies, particularly relative hypogonadism, in individuals with metabolic syndrome.
  • To explore the potential of correcting these hormonal derangements to improve metabolic parameters.
  • To elucidate the underlying mechanisms, including the role of testosterone, in visceral fat accumulation.

Main Methods:

  • Review of recent findings on subtle endocrinopathies in metabolic syndrome patients.
  • Analysis of intervention studies involving correction of relative hypogonadism in men with visceral obesity.
  • Examination of underlying mechanisms, including the regulatory role of testosterone.

Main Results:

  • Correction of relative hypogonadism in men with visceral obesity and metabolic syndrome manifestations led to decreased abdominal fat mass.
  • Intervention studies showed reversal of glucose intolerance and serum lipoprotein abnormalities.
  • Testosterone plays a regulatory role in counteracting visceral fat accumulation, and low testosterone levels are a risk factor for visceral obesity.

Conclusions:

  • Subtle endocrinopathies, especially relative hypogonadism, are prevalent in individuals with metabolic syndrome.
  • Therapeutic correction of hypogonadism can ameliorate key features of metabolic syndrome, including visceral obesity and metabolic dysfunction.
  • Testosterone deficiency may be both a risk factor for and a contributor to visceral obesity and metabolic syndrome.

Related Experiment Videos